Genetic prophecy : beyond the double helix / Zsolt Harsanyi, Richard Hutton.

  • Harsanyi, Zsolt, 1944-
Date:
[1981], ©1981
Catalogue details

Licence: Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)

Credit: Genetic prophecy : beyond the double helix / Zsolt Harsanyi, Richard Hutton. Source: Wellcome Collection.

    339/360 (page 323)
    Index for PKU, 175-176, 229, 248-249, 250-251, 252, 255, 256 right of knowing vs. burden of knowing, 263-265, 269, 272-273 for sickle-cell trait, 115-116, 243-245, 249-251, 252, 255, 256 for Tay-Sachs gene, 251-252 trade-offs and risks involved, 246-247, 254-255 Genetic selection, 147-148, 152, 154, 168 Genetic therapy, adult, 275 Genetic variation, 19, 148, 153-158, 269 Genetics: lacking in medical curricula, 47, 268 lag of physicians' and family planning counselors' knowl¬ edge in, 266-268 social and political misuse of, 164-165, 221-222, 231, 247, 255, 262, 271-272 Genetics Society of America, 230 Genital ulcerations, table 65 George III, King of England, 135 Georgia State University, 234 Gerald, Park, 218, 237 Gerontology, 43 Giphart, M. J., 78 Glaucoma, table 66 Glomerulonephritis, table 67 Glucose-6-phosphate dehydroge¬ nase. See G-6-PD Glueck, Charles, 23, 26 Glutamate-pyruvate transami¬ nase (GPT), 94 Gluten sensitivity, 72 and celiac disease, 127-129 enteropathy, table 65 HLA markers for, table 65, 128 Goiters, 134-135 Goldwater, Barry, 255 Gonorrhea, urethritis from, table 66 Gorer, Peter, 55-56, 57 GPT (glutamate-pyruvate trans¬ aminase), 94 Garves' disease, table 65 Great Plague of London, 35 Greeks, Cooley's anemia inci¬ dence in, 158 Gregariousness, 232, 233 Gross, Ludwik, 56-57, 62 Guthrie, Woody, 211 Guy's Hospital, London, 55, 141 H2 system of mouse antigens, 56-58 Hair dyes, 108 Haldane, J. B. S., 152 Hallucinogens, 207 Harbor-UCLA Medical Center, 130 Harvard Medical School, 195 Harvard University, 238 Haskell Laboratory for Toxicol¬ ogy and Industrial Medi¬ cine, DuPont, 116 Hay fever (ragweed pollinosis), table 64, 73 HbS hemoglobin, 114-115 HDL (high-density lipoproteins), 25-27 controlling of level of, 27 environmental factors in level of, 27 and resistance to heart disease, 25-26, 27, 29 tests for, 27 Health care costs. See Medical costs [ 323 ]